Blood test can identify risk for cognitive decline

According to a research published in scientific journal Nature stated that researchers have discovered and legalized a new blood test that can forecast with as high of 90 percent accuracy stating that a healthy person can develop the mild cognitive impairment or the Alzheimer's disease within the next three years. It is a step forward in the scientific development. Now medical practitioners can help their patients well in time. This forecast can help the medical practitioners to identify the fore-coming trouble and can deal accordingly for the benefit of the patient. One of the co-researchers, Howard J. Federoff, MD, PhD, professor of neurology and executive vice president for health sciences at Georgetown University Medical Center explains this test further, “Our novel blood test offers the potential to identify people at risk for progressive cognitive decline and can change how patients, their families and treating physicians plan for and manage the disorder.”